Changes after publication
March 2014: implementation section updated to clarify that adefovir dipivoxil and peginterferon alfa-2a are recommended as options for treating chronic hepatitis B. Additional minor maintenance update also carried out.
June 2013: Recommendations 1.2–1.4 replaced by recommendations 1.5.13–1.5.15 in Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young people and adults (NICE clinical guideline 165).
March 2012: minor maintenance